ACCESS Newswire

AGFA HealthCare

14.5.2024 15:06:12 CEST | ACCESS Newswire | Press release

Share
St. Vincent's Private Hospital, the Largest Acute Private Hospital in Dublin, Chooses AGFA HealthCare's Enterprise Imaging for Radiology

MORTSEL, BELGIUM / ACCESSWIRE / May 14, 2024 / AGFA HealthCare is pleased to announce that St. Vincent's Private Hospital in Dublin, Ireland, has chosen to implement AGFA HealthCare's Enterprise Imaging. This five-year agreement includes Enterprise Imaging for both Radiology and Breast Imaging, structured and precision reporting modules, Best in KLAS XERO® Universal Viewer, AGFA's Scheduling solution, Business Intelligence, Patients and Clinician portal, and a Managed Services contract.

To view this piece of content from cdn.nwe.io, please give your consent at the top of this page.

Near-real-time image access

St. Vincent's Private Hospital is the largest acute private hospital in Dublin and part of the only integrated multi-hospital campus in Ireland. The Enterprise Imaging Platform will deliver the advanced capabilities and robust availability that the hospital needs.

"St. Vincent's Private Hospital is a unique healthcare environment. As we are on the same grounds as St. Vincent's University Hospital, we can share resources, expertise and medical facilities with this leading academic teaching establishment. This enables us to deal with a high volume of patients, often who have complex medical requirements. Imaging is core to this care. AGFA HealthCare's Enterprise Imaging will give us the reliable, robust platform that we need, whilst delivering very fast access to studies. Furthermore, AGFA HealthCare is able to support this system with managed services and monitoring that will maximise our uptime, while minimising the burden on our own resources," says Tim Aseervatham, Healthcare/Diagnostic Informatics Manager for St. Vincent's Private Hospital.

"We are proud of the trust that St. Vincent's Private Hospital - a key healthcare player in Ireland - is placing in AGFA HealthCare. This further demonstrates the success of our long-standing commitment to delivering solutions that improve the delivery of healthcare to patients in both the private and public healthcare sector in Ireland and beyond. Enterprise Imaging enables the creation of a secure, modular and scalable ecosystem, which helps the hospital to reduce complexity, improve clinical collaboration, and enhance workflow efficiency. By empowering all users to access imaging studies in near-real-time, it will allow them to focus on tasks that add value to both their patients' care and experience," says Colin Foley, Regional Business Manager for AGFA HealthCare Ireland.

Seamless care and collaboration

The Radiology Department at St. Vincent's Private Hospital is one of the largest radiology services in the country, offering a full range of diagnostic and interventional services. It performs over 65,000 studies every year, including X-ray, CT, mammography, MRI, ultrasound, fluoroscopy and DEXA. The department is made up of 18 consultant radiologists working in conjunction with highly qualified radiographers and nurses and supported by experienced administrators.

Enterprise Imaging will integrate with the hospital's existing pillar and patient referral systems and will replace all paper-based workflows. The five-year agreement includes:

  • Enterprise Imaging for Radiology and Breast Imaging: a one-of-a-kind, seamless and secure platform designed to build a connected, collaborative, and scalable community of care. Enterprise Imaging delivers "life in flow" to meet radiologists' daily challenges through a highly focused, efficient and customisable experience.
  • Best in KLAS XERO® Universal Viewer: provides patient-centric image access across the enterprise, with pixel streaming in near-real time on almost any device with no downloads or data moves, and enhanced viewing with clinical depth, collaboration and sharing, all on a single web viewer.
  • Business Intelligence: enables easy-to-access reports and tools for gathering, organising, analysing and managing clinical, quality, financial and administrative data.
  • Scheduling: facilitates managing appointments and orders for even the most complex imaging procedures in one easy and quick web-based application.
  • Structured and precision reporting, including ACR BI-RADS® ATLAS and ACR PI-RADS® ATLAS: fully integrated in the Enterprise Imaging Platform, it combines customisation with automation to support clear communication and enhanced decision-making.
  • Workflow orchestration: intelligently and automatically assigns tasks to radiologists, based on the chosen criteria.
  • Collaboration tools: support multidisciplinary teams with the multimedia patient images they need, wherever they are, including at the point of care. 
  • Actionable findings notification: closes the loop between radiologists and clinicians through rapid and effective communication of incidental and critical imaging findings.
  • Native 3D tools and advanced visualisation, plus seamlessly embedded third-party clinical application.
  • Portal for patients and physicians: makes it easy for patients and physicians outside of the hospital to access medical images and results.
  • Managed services and monitoring: support optimal maintenance and uptime of this flexible and high-performance solution.

We are delighted to welcome St Vincent's Hospital to #TeamAGFA and are honoured to add such a prestigious hospital to our customer base.

About AGFA HealthCare

At AGFA HealthCare, we are transforming the delivery of care - supporting healthcare professionals across the globe with secure, effective, and sustainable imaging data management. As a company, we are dedicated to our customers, and we have harnessed a value framework of Mission, Vision and Customer Delivery Principles into our routine operations. Through these principles, we commit a consistent high-yield code of conduct to our associates - channelling our experience and aspirations to all of our stakeholders. Our Empowerer profile supports our focus on creating an exceptional experience through the power of technology and is an integral foundation to our company standards. AGFA HealthCare is a division of the Agfa-Gevaert Group. For more information on AGFA HealthCare, please visit www.agfahealthcare.com and follow us on LinkedIn.

AGFA and the Agfa rhombus are registered trademarks of Agfa-Gevaert N.V. Belgium or its affiliates. XERO® is a registered trademark of AGFA HealthCare N.V., Belgium. BI-RADS and PI-RADS are registered trademarks of the American College of Radiology. All rights reserved. All information contained herein is intended for guidance purposes only, and the characteristics of the products and services described in this publication can be changed at any time without notice. Products and services may not be available for your local area. Please contact your local sales representative for availability information. AGFA HealthCare diligently strives to provide as accurate information as possible but shall not be responsible for any typographical error.

Contact Information

Buse Kayar
buse.kayar@issuerdirect.com

SOURCE: AGFA HealthCare

To view this piece of content from stats.nwe.io, please give your consent at the top of this page.

View the original press release on newswire.com.

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESS Newswire

DK

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

PharmaNest and Mediar Therapeutics Collaborate to Quantify ECM and Fibrosis Remodeling in the EncompaSSc Phase 2 Trial of MTX-474 in Diffuse Cutaneous Systemic Sclerosis30.9.2026 19:00:00 CEST | Press release

PRINCETON, NJ / ACCESS Newswire / September 30, 2026 / PharmaNest, Inc. an AI-enabled digital pathology company specializing in the quantitative and spatial characterization of fibrosis and Mediar Therapeutics, Inc., a clinical-stage biotechnology company pioneering first-in-class therapies to halt and reverse fibrosis, today announced a collaboration to integrate advanced digital pathology into Mediar's ongoing EncompaSSc Phase 2 clinical trial of MTX-474 in patients with diffuse cutaneous systemic sclerosis (dcSSc). MTX-474 is a first-in-class human IgG1 monoclonal antibody designed to neutralize EphrinB2 signaling, a pathway implicated in myofibroblast activation, extracellular matrix (ECM) deposition and tissue remodeling known to drive fibrosis in SSc. The randomized, double-blind, placebo-controlled EncompaSSc Phase 2 study is evaluating the safety and efficacy of MTX-474 in patients with dcSSc. Under the collaboration, PharmaNest will apply its FibroNest™ AI-enabled digital path

Innodata Opens Motion-Capture AI Lab to Help Humanoids Move Like Humans30.9.2026 15:50:00 CEST | Press release

NEW YORK, NY / ACCESS Newswire / September 30, 2026 / Innodata Inc. (Nasdaq:INOD) today announced the opening of a new R&D laboratory that is designed to generate the data needed to train the next generation of human-like robots and independently validate the performance data that robots generate internally. Innodata developed the lab in collaboration with Vicon, a leader in motion capture who consulted on the lab design and continues to provide technical consulting. The New Jersey-based lab is equipped with high-precision, low-latency infrared optical tracking cameras that measure movement down to the sub-millimeter level-a degree of accuracy that methods such as wearable inertial measurement unit (IMU) sensors and single-camera (monocular) video analysis typically cannot match. The lab addresses an urgent need for high-quality training data for humanoids, industrial robots, and other forms of physical AI. While many other data providers infer 3D motion by analyzing 2D video, Innodata

Clean Air Metals Files Interim Financial Statements for the Six Months Ended July 31, 202630.9.2026 00:45:00 CEST | Press release

THUNDER BAY, ON / ACCESS Newswire / September 29, 2026 / Clean Air Metals Inc. ("Clean Air Metals" or the "Company") (TSXV:AIR)(FRA:CKU)(OTC PINK:CLRMF) announces that it has filed its unaudited consolidated interim financial statements and management's discussion and analysis for the six-month period ended July 31, 2026, available for viewing on www.sedarplus.ca. Financial HighlightsTotal assets as at July 31, 2026 of $35,465,204Total cash as at July 31, 2026 of $422,500Working capital deficiency as at July 31, 2026 of $3,188,114Shareholder's equity as at July 31, 2026 of $31,803,864 During the six-month period ended July 31, 2026, the Company incurred $164,309 in cost for exploration activities at the Thunder Bay North project. During the second fiscal quarter, the Company focused on finalizing the proposed amalgamation while continuing discussions on Advanced Exploration permitting and re-assessment of past geophysical work to highlight areas of focus for drilling and geophysics in

Continent 8 and FuturePath AI Launch Future8: Accountable AI for Regulated Industries29.9.2026 15:00:00 CEST | Press release

LISBON, PT / ACCESS Newswire / September 29, 2026 / Continent 8 Technologies and FuturePath AI today launched Future8, an AI-native operating company built for regulated operators, formed as a joint venture between the two companies. Announced at SBC Summit Lisbon, Future8 combines FuturePath's enterprise AI applications platform with Continent 8's licensed global operating footprint, enabling the iGaming industry to deploy auditable AI without compromising compliance, data sovereignty and operational control. Built for highly regulated environments, Future8 enables operators to move from AI experimentation to production deployment by embedding governance, approvals and auditability into every workflow from day one. Continent 8 brings licensed data centers and a private global network spanning more than 100 locations, built over 28 years serving the biggest iGaming and online brands, along with AI-enabled Global Capability Centers in India, the Philippines and Bulgaria. The company als

Europe SPAC Summit 2026 Invites European Private Companies to Explore the SPAC Path to U.S. Public Markets29.9.2026 15:00:00 CEST | Press release

NEW YORK, NY AND ZURICH, SWITZERLAND / ACCESS Newswire / September 29, 2026 / A growing number of European companies in frontier technologies, critical minerals, advanced manufacturing, defense tech, energy, and consumer sectors are evaluating a merger with a special purpose acquisition company (SPAC) as a faster route to a U.S. listing, a valuation that reflects global investor demand, and access to follow-on capital. The Europe SPAC Summit 2026 (ESPAC'26), co-hosted by AUM Advisors and MBP Global, is inviting the CEOs, CFOs, founders, and board members of late-stage European private companies to The Dolder Grand in Zurich on Thursday, December 10, 2026, to learn how the process works and to meet the investment bankers, institutional investors, and SPAC sponsors who make these transactions happen. Attendance is by invitation only and free of charge for qualified companies. Europe's recent de-SPACs show what is possible. Kyivstar, Ukraine's largest mobile operator, listed on Nasdaq thr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye